VapC Toxins from Mycobacterium tuberculosis and Their Antitoxins
Author Information
Author(s): Ahidjo Bintou Ahmadou, Kuhnert Diane, McKenzie Joanna L., Machowski Edith E., Gordhan Bhavna G., Arcus Vickery, Abrahams Garth L., Mizrahi Valerie
Primary Institution: Medical Research Council, National Health Laboratory Service, University of the Witwatersrand
Hypothesis
The study investigates the role of VapC toxins and their cognate VapB antitoxins in the physiology of Mycobacterium tuberculosis.
Conclusion
The study demonstrates that VapC toxins can inhibit growth in Mycobacterium tuberculosis, and their toxicity is neutralized by cognate VapB antitoxins.
Supporting Evidence
- Four VapC proteins were found to inhibit growth in Mycobacterium smegmatis.
- The toxicity of VapC proteins was neutralized by their cognate VapB antitoxins.
- The study identified a correlation between the expression levels of VapC proteins and their toxic effects.
- VapC proteins exhibited sequence-selective RNase activity.
Takeaway
Some proteins in bacteria can be harmful, but they have helpers that can stop them from being mean. This study looks at how these helpers work in a germ that causes tuberculosis.
Methodology
The study used conditional expression systems to assess the toxicity of VapC proteins in Mycobacterium smegmatis and Mycobacterium tuberculosis.
Limitations
The study did not explore the effects of all VapC proteins and their interactions in various environmental conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website